Ae Wealth Management LLC Black Diamond Therapeutics, Inc. Transaction History

Ae Wealth Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$1.77 - $3.03 $26 - $45	-15 Reduced 0.09%	15,920 $44,000
Q3 2023 Oct 11, 2023	BUY	$2.87 - $4.99 $43 - $74	15 Added 0.09%	15,935 $45,000
Q2 2023 Jul 10, 2023	SELL	$1.43 - $6.18 $28,600 - $123,600	-20,000 Reduced 55.68%	15,920 $80,000
Q1 2023 Apr 14, 2023	SELL	$1.35 - $3.14 $36 - $84	-27 Reduced 0.08%	35,920 $67,000
Q4 2022 Jan 31, 2023	SELL	$1.27 - $2.51 $12 - $25	-10 Reduced 0.03%	35,947 $64,000
Q3 2022 Oct 25, 2022	SELL	$1.68 - $4.01 $719 - $1,716	-428 Reduced 1.18%	35,957 $61,000
Q2 2022 Aug 03, 2022	BUY	$1.5 - $3.63 $17,133 - $41,461	11,422 Added 45.76%	36,385 $90,000
Q1 2022 Apr 18, 2022	BUY	$2.66 - $5.61 $23,482 - $49,525	8,828 Added 54.71%	24,963 $69,000
Q4 2021 Jan 20, 2022	BUY	$5.18 - $8.48 $83,579 - $136,824	16,135 New	16,135 $86,000

106

49M

798K

1.36M

Ticker BDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,339,500
Market Cap $86.1M
Description
Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...

Get notified when there are updates to the investment portfolio of Ae Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ae Wealth Management LLC with notifications on news.